{"name":"Universita di Verona","slug":"universita-di-verona","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"Hyperbolic tapering","genericName":"Hyperbolic tapering","slug":"hyperbolic-tapering","indication":"General dosing strategy applicable to various medications requiring gradual discontinuation","status":"marketed"},{"name":"Linear tapering","genericName":"Linear tapering","slug":"linear-tapering","indication":"Other","status":"marketed"}]},{"name":"Immunology","slug":"immunology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"efalizumab plus acitretin","genericName":"efalizumab plus acitretin","slug":"efalizumab-plus-acitretin","indication":"Moderate to severe plaque psoriasis","status":"marketed"}]}],"pipeline":[{"name":"Hyperbolic tapering","genericName":"Hyperbolic tapering","slug":"hyperbolic-tapering","phase":"marketed","mechanism":"Hyperbolic tapering is a dosing strategy that reduces medication dose according to a hyperbolic mathematical function rather than linear reduction.","indications":["General dosing strategy applicable to various medications requiring gradual discontinuation"],"catalyst":""},{"name":"Linear tapering","genericName":"Linear tapering","slug":"linear-tapering","phase":"marketed","mechanism":"Linear tapering is a dosing strategy that gradually reduces medication dose in a linear fashion over time to minimize withdrawal effects and allow physiological adaptation.","indications":[],"catalyst":""},{"name":"efalizumab plus acitretin","genericName":"efalizumab plus acitretin","slug":"efalizumab-plus-acitretin","phase":"marketed","mechanism":"Efalizumab blocks T-cell activation and migration to skin while acitretin reduces keratinocyte proliferation and differentiation, together providing dual immunological and differentiation-based control of psoriasis.","indications":["Moderate to severe plaque psoriasis"],"catalyst":""}],"recentEvents":[],"realNews":[],"patents":[],"drugCount":3,"phaseCounts":{"marketed":3},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}